Facebook
Twitter
Telegram
Report an ErrorCatabasis Pharmaceuticals, Inc. Balance Sheet 2011-2024 | CATB
Annual Balance Sheet Catabasis Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-23.9 M | -7.65 M | -15.3 M | -13.9 M | -17.9 M | -53.8 M | -9.92 M | -30.5 M | - | - |
Long Term Debt |
- | - | - | - | 2.48 M | 5.74 M | 4.44 M | - | - | - |
Total Non Current Liabilities |
397 K | 1.03 M | 56 K | 89 K | 2.8 M | 5.92 M | 84.8 M | 80.3 M | - | - |
Total Current Liabilities |
6.39 M | 5.03 M | 4.17 M | 6.02 M | 8.32 M | 7.81 M | 4.23 M | 2.93 M | - | - |
Total Liabilities |
6.79 M | 6.06 M | 4.23 M | 6.1 M | 11.1 M | 13.7 M | 89 M | 83.2 M | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-261 M | -224 M | -197 M | -171 M | -144 M | -108 M | -75.4 M | -53.5 M | - | - |
Total Assets |
47.5 M | 41.8 M | 39.2 M | 17.9 M | 40.2 M | 64.2 M | 16 M | 31 M | - | - |
All numbers in USD currency